Governance Roche Holding AG

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:31:44 2024-09-16 am EDT			5-day change	1st Jan Change
264.10 ^CHF	-0.56%		-1.16%	+8.02%

04:43pm	Poseida Gets Regenerative Medicine Advanced Therapy Designation for Myeloma Treatment; Shares Rise	MT
09:32am	Roche: Ocrevus Zunovo approved by the FDA	CF

Executive Committee: Roche Holding AG

Manager

Positions heldSince

Thomas Schinecker

49 year

Chief Executive Officer

2023-03-14

Levi Garraway

Chief Tech/Sci/R&D Officer

Pascale Schmidt

51 year

Compliance Officer

2019-12-31

Claudia Boeckstiegel

60 year

General Counsel

2020-03-31

Annette Luther

54 year

Corporate Secretary

2020-03-31

Alan Hippe

57 year

Chief Tech/Sci/R&D Officer	2011-09-06
Director of Finance/CFO	2011-06-05

Cristina A. Wilbur

57 year

Human Resources Officer

Bruno Eschli

Investor Relations Contact

Composition of the Board of Directors: Roche Holding AG

Director

CommitteesSince

Severin Schwan

57 year

Executive Committee

2012-12-31

André S. Hoffmann

66 year

Governance Committee	1995-12-31
Nominating Committee	1995-12-31
Compensation Committee Chair	2013-04-07
Governance Committee Chair	1995-12-31

Claudia Dyckerhoff

58 year

Governance Committee	2016-02-29
Compensation Committee	2016-04-20

Anita Hauser

55 year

Compensation Committee	2006-12-31
Governance Committee	2017-03-13

Ulf Mark Schneider

59 year

Audit Committee	2014-09-30
Governance Committee	2014-09-30

Bernard Poussot

72 year

Compensation Committee

2014-12-31

Joerg Duschmale

40 year

Audit Committee

2020-03-16

Patrick Frost

56 year

Audit Committee

2020-03-16

Richard P. Lifton

71 year

Director/Board Member	2015-03-02
Independent Dir/Board Member	2015-03-02

Jemilah Mahmood

Director/Board Member

Akiko Iwasaki

Director/Board Member

Latest Appointments: Roche Holding AG

Page Industries Limited Announces Change in Directorate	Aug. 08	CI
JW Therapeutics Co. Ltd Announces CEO Changes	Jul. 31	CI
Zealand Pharma Names Chief Commercial Officer	Jul. 30	MT
Immunic, Inc. Appoints Simona Skerjanec as Member of the Board	Jul. 24	CI
Nkarta, Inc. Appoints George Vratsanos as Board of Directors	Jun. 13	CI
Roche appoints Director of Corporate Business Development	May. 27	CF
Roche Announces Management and Board Committee Changes	May. 27	CI

More news

Former Officers and Directors: Roche Holding AG

Insider

Positions held

SinceUntil

Christoph Franz

Chairman	2014-02-28	2023-03-14
Independent Dir/Board Member	2014-02-28	2023-03-14

Julie Brown

Director/Board Member	2016-02-29	2022-09-25
Independent Dir/Board Member	2016-02-29	2022-09-25

William Pao

Corporate Officer/Principal

2014-04-30

2022-03-17

Paul Bulcke

Director/Board Member	2011-06-05	2021-12-31
Independent Dir/Board Member	2011-09-05	2012-03-14

Gottlieb A. Keller

General Counsel	2010-01-12	2020-03-30
Corporate Secretary	2007-12-31	2020-03-30

Andreas Oeri

Director/Board Member	2010-01-12	2020-03-16
Independent Dir/Board Member	2011-09-05	2020-03-16
Corporate Officer/Principal	1995-12-31	2010-01-12

John Bell

Director/Board Member	2009-09-16	2020-03-16
Independent Dir/Board Member	2011-03-31	2011-09-11
Corporate Officer/Principal	2000-12-31	2009-09-16

Stephan Feldhaus

Public Communications Contact

2010-09-07

2019-09-29

Peter Voser

Director/Board Member	2011-01-31	2019-06-29
Independent Dir/Board Member	2011-09-05	2012-03-14

John Reed

Corporate Officer/Principal

2013-04-01

2018-04-01

Roland Diggelmann

Corporate Officer/Principal

2011-12-31

2017-12-31

Pius Baschera

Director/Board Member	2010-01-12	2017-03-30
Independent Dir/Board Member	2011-09-05	2011-09-11

Beatrice Weder di Mauro

Director/Board Member	2010-01-12	2016-02-29
Independent Dir/Board Member	2011-07-28	2011-09-11

DeAnne Shirley Julius

Director/Board Member	2010-01-12	2016-02-29
Independent Dir/Board Member	2011-09-05	2016-02-29
Corporate Officer/Principal	2001-12-31	2010-01-12

Silvia Ayyoubi

Human Resources Officer

2010-01-12

2015-12-30

Hyam Levitsky

Corporate Officer/Principal

2011-07-31

2015-01-31

Michael Varney

Corporate Officer/Principal

2014-12-31

Richard Scheller

Corporate Officer/Principal

2008-12-31

2014-12-30

William Burns

Director/Board Member	2010-02-28	2014-03-03
Independent Dir/Board Member	2010-02-28	2012-03-14

Franz Humer

Chairman

2011-09-05

2014-03-03

Lodewijk J. R. de Vink

Director/Board Member	2010-01-12	2013-03-04
Independent Dir/Board Member	2011-04-10	2011-09-11
Corporate Officer/Principal	2003-12-31	2010-01-12

Bruno Gehrig

Director/Board Member	2003-12-31	2013-03-04
Independent Dir/Board Member	2003-12-31	2012-03-14

Jean-Jacques Garaud

Corporate Officer/Principal

2006-12-31

2012-06-29

Klaus Gustav Strein

Corporate Officer/Principal

2011-09-13

Erich Hunziker

Director/Board Member	2011-01-17	2011-01-17
Chief Tech/Sci/R&D Officer	2010-01-12	2011-03-30
Director of Finance/CFO	2001-09-30	2011-03-30

David M. Goldstein

Corporate Officer/Principal

1993-12-31

2010-12-31

Wolfgang Ruttenstorfer

Director/Board Member	2010-01-12	2010-12-13
Independent Dir/Board Member	2006-12-31	2010-12-31

Walter Frey

Director/Board Member	2010-01-12	2010-12-13
Independent Dir/Board Member	2000-12-31	2010-12-31
Corporate Officer/Principal	2000-12-31	2010-01-12

Peter Brabeck-Letmathe

Director/Board Member

2010-02-28

Arthur Levinson

Director/Board Member	2010-02-28	-
Independent Dir/Board Member	2011-04-25	2011-09-11

Per-Olof Attinger

Corporate Officer/Principal

2009-12-31

Eduard Enrico Holdener

Corporate Officer/Principal

1994-12-31

2006-12-31

Michael Burgess

Corporate Officer/Principal

2011-10-23

Rolf Hänggi

Director/Board Member

2005-12-31

Dirk W. Kirsten

Corporate Officer/Principal

2001-12-31

2003-12-31

Domenico Scala

Corporate Officer/Principal	1994-12-31	1999-12-31
Treasurer	1999-12-31	2002-12-31

Henri-Paul Meier

Investor Relations Contact	2011-09-08	-
Public Communications Contact	2002-03-14	-

Horst Teltschik

Director/Board Member	2010-01-12	-
Corporate Officer/Principal	2001-12-31	2010-01-12

Anton Affentranger

Director of Finance/CFO

Jürg Witmer

Public Communications Contact

1977-12-31

Vincent Charlon

Corporate Officer/Principal

1989-12-31

1997-12-31

Rolf Schläpfer

Public Communications Contact

1996-12-31

Unni Hjelmaas

Corporate Officer/Principal

1996-12-31

Gerard Farmer

General Counsel

1988-12-31

Pierre Jaccoud

Corporate Secretary

1987-12-31

Simon Roitt

Corporate Officer/Principal

Tim George

Sales & Marketing

Ken A. Brameld

Corporate Officer/Principal

Urs Jaisli

Compliance Officer

2013-01-30

Marc Salzberg

Corporate Officer/Principal

Wing-Kai Chan

Corporate Officer/Principal

Robert Salcedo

Corporate Officer/Principal

Eva Losert

Public Communications Contact

Ivan Melezínek

Corporate Officer/Principal

Peter Johann

Sales & Marketing

Alexander Klauser

Public Communications Contact

2010-09-07

Andreas Greuter

General Counsel

Stefan Ryser

Human Resources Officer

Markus Hosang

Corporate Officer/Principal

Andreas Emmenegger

Corporate Officer/Principal

Tom Edward Pike

Corporate Officer/Principal

George Abercrombie

Corporate Officer/Principal

Karl Mahler

Investor Relations Contact	-	-
Public Communications Contact	-	-

Jean-Pierre Obrecht

Corporate Officer/Principal

Daniel O'Day

Corporate Officer/Principal

Kuno Sommer

Corporate Officer/Principal

Garner William

Corporate Officer/Principal

Ann Moravick

Corporate Officer/Principal

Melanie Wolf

Public Communications Contact

Ashok Dhanrajgir

Corporate Officer/Principal

Dámaso Molero

Corporate Officer/Principal

Peter Boyle

Investor Relations Contact

Fritz Hoffmann-la Roche

Founder

Age distribution of managers

Parity Men Women

Male	19
Female	8

Of which Executive Committee

Male	5
Female	3

Of which Directors

Male	10
Female	1

ESG Refinitiv

A+

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Employees

103,605

Sector

Pharmaceuticals

Calendar

06:00am - Pharma Day

More about the company

Departures of Key Persons

Franz Humer

Chairman

2011-09-05 2014-03-03

Fritz Gerber

Chief Executive Officer

- 2020-05-09

Christoph Franz

Chairman

2014-02-28 2023-03-14

Governance Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Executive Committee: Roche Holding AG

Composition of the Board of Directors: Roche Holding AG

Latest Appointments: Roche Holding AG

Former Officers and Directors: Roche Holding AG

Age distribution of managers

Parity Men Women

Environment

Governance

Controversy

Company Profile

Departures of Key Persons

Governance Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Executive Committee: Roche Holding AG

Composition of the Board of Directors: Roche Holding AG

Latest Appointments: Roche Holding AG

Former Officers and Directors: Roche Holding AG

Age distribution of managers

Parity Men Women

Environment

Social

Governance

Controversy

Company Profile

Departures of Key Persons